Results from a survey from an independent, third party research firm, TechValidate, indicate that more than half of 606 ...

Galapagos CEO Henry Gosebruch says the recent uptick in M&A activity is a positive development for the biotech as it pursues ...

“This change is deeply troubling because it is false and lacks transparency. There is no scientific rationale for CDC to ...

Though CMC barriers remain, strategic planning in the early development stages can guide a CGT product to success, noted ...

US-based Aspen Neuroscience has closed a Series C funding round, raising $115m to further the clinical development of its ...

Alvotech and Advanz Pharma have announced EC marketing authorisations for Gobivaz, a biosimilar to Simponi, across the EEA.

Innovative linkers, connecting antibodies to payloads, are fine-tuning ADC selectivity while broadening their therapeutic ...

Valo will use its trove of patient records and biobank samples to pinpoint potential targets for Merck’s pipeline expansion.

Moderna is to expand its US manufacturing capabilities with the onshoring of drug product manufacture to its existing Moderna ...

Novartis' two new sites in North Carolina fall under the Swiss pharma’s $23bn US manufacturing onshoring ploy.

Regeneron has won two US Food and Drug Administration (FDA) approvals for Eylea HD (aflibercept), adding another indication ...

Pfizer and Tris Pharma have agreed to pay $41.5m to settle allegations by the Texas Attorney General Ken Paxton ...